...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Have a great Sunday, especially those of you like me that are celebrating Orthodox Easter ... As well as those of you who are also like me and mourning another Maple Leafs Game 7 exit ... Ugggh!

Sincerely,

George et al

Message: Sensitivity on steroids..

Its almost impossible to say anything anymore without offending someone....even a banal little "bite me" directed at nobody in particular seems to get some upset. Oh well....whaddyer gonna do? I myself am offended when someone uses CAPS, underline, italics and bold ALL AT THE SAME TIME.

I'm bullish on RVX and I'm done walking on eggshells, worrying about offending someone....We are in phase III with Apabetalone and have phase II trial results which showed strong enough results in post hoc analysis to pursue the BETonMACE trial....if Apabetalone succeeds in achieving RRR of MACE in Diabetes patients.....and then proves equally successful in other indications like Kidney disease, thrombosis, alzheimers and orphan indications....then i don't think a MC of even $10 billion USD is unrealistic.

Risks? Of course....they might not succeed, but if they do look out.

1
Oct 19, 2016 11:28AM
Share
New Message
Please login to post a reply